Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05707013 · ClinicalTrials.gov registry record · NA
HP Arize 3D Orthotics for Planar Fasciitis
A NA study of Plantar Fascitis, sponsored by Prisma Health-Midlands.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05707013: Active NA study of Plantar Fascitis, sponsored by Prisma Health-Midlands.
NCT05707013 is a NA study of Plantar Fascitis that is active but no longer recruiting, run by Prisma Health-Midlands. The registered enrollment target is 30 participants, below the 91-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05707013, a NA study of Plantar Fascitis, is active but no longer recruiting, sponsored by Prisma Health-Midlands.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailored to the patient, quickly, easily, accurately, and reliably. This pilot study will evaluate the effectiveness and clinical benefit of 3D printed foot orthotics compared to traditionally fabricated custom-made orthotics and assess compliance and patient satisfaction in patients with plantar fasciitis.
Primary Outcome
Patient-reported compliance with traditionally fabricated or 3D-printed orthotics will be assessed at 4 weeks and 8 weeks post-initiation of orthotic wearing via a study-specific survey. This survey includes questions related to how often the patient wore their orthotics, the ease of the process, and fit and feel of the orthotics, and any experienced side effects. This survey was developed by the research team and includes subjective responses to questions; there is no score associated with this
Conditions Studied
Interventions
- DEVICE HP Arize 3D-Printed Orthotics
- DEVICE Traditional Orthotics
Study Locations (1)
South Carolina
- Prisma Health - Midlands - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-19 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What the registry record for NCT05707013 still lists
NCT05707013 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 91-participant average among 7 other Plantar Fascitis trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Plantar Fascitis appearing as the primary indexed condition, and to 2 interventions - of which HP Arize 3D-Printed Orthotics is the first listed.
NCT05707013 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05707013 about?
NCT05707013 is a clinical study titled "HP Arize 3D Orthotics for Planar Fasciitis". Currently 77% of Americans experience foot pain, of which a large portion can be attributed to plantar fasciitis. The Arize Orthotic solution, developed in collaboration with podiatrists and leading industry experts, is a new digital solution that helps podiatrists create custom foot orthoses tailo...
What is the current status of trial NCT05707013?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-19. Estimated completion is 2026-06-30.
What conditions does trial NCT05707013 study?
This clinical trial studies the following conditions: Plantar Fascitis.
What interventions are being tested in trial NCT05707013?
The interventions under investigation include: HP Arize 3D-Printed Orthotics (DEVICE), Traditional Orthotics (DEVICE).
Who is sponsoring clinical trial NCT05707013?
This trial is sponsored by Prisma Health-Midlands, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05707013 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fascitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dynamic Versus Static Night Splinting of Plantar Fasciitis
RECRUITING · NA
-
Plantar Fasciitis Randomized Clinical Control Trial
RECRUITING · NA
-
Shockwave Therapy for Plantar Fasciitis RCT
ACTIVE NOT RECRUITING · NA
-
Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy
COMPLETED · NA
-
Effects of Exercise Versus Exercise and Instrument-Assisted Soft Tissue Mobilization for Plantar Fasciopathy Treatment
COMPLETED · NA
-
Acupuncture for Plantar Fasciosis in the Primary Care Setting
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI